News
Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $280.75, accompanied by a ...
Humana is scheduled to release its second-quarter results later this month, with analysts projecting single-digit earnings ...
Humana (NYSE:HUM) recently launched the inaugural Humana Cognitive Gamesâ„¢ to promote brain health among older adults, coinciding with their tenth year sponsoring the National Senior Games. This ...
For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
The Cigna Group's fundamentals are solid, but the stock is fairly valued versus peers, not a bargain. Click here to find out ...
This was the stock's fourth consecutive day of losses.
1hon MSN
The S&P 500 ticked 0.3% higher on Wednesday, July 16, 2025, as President Trump sought to ease concerns that a dismissal of ...
Buying $1000 In UHS: If an investor had bought $1000 of UHS stock 20 years ago, it would be worth $6,367.41 today based on a price of $184.05 for UHS at the time of writing.
1d
InvestorsHub on MSNLongevity Health Shares Skyrocket After All-Stock Merger with THPlasmaShares of Longevity Health Holdings Inc. (NASDAQ:XAGE) soared 155% on Tuesday after the company announced a definitive ...
1d
Zacks Investment Research on MSNWhy Humacyte, Inc. (HUMA) Dipped More Than Broader Market TodayIn the latest close session, Humacyte, Inc. (HUMA) was down 7.69% at $2.28. The stock trailed the S&P 500, which registered a daily loss of 0.4%. Meanwhile, the Dow lost 0.98%, and the Nasdaq, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results